Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamic

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities


5. Global Acute Respiratory Distress Syndrome Market


6. Global Acute Respiratory Distress Syndrome Market Share Analysis

6.1 By Types
6.2 By End User
6.3 By Countries


7. Type

7.1 Diagnosis
7.2 Treatment


8. End User

8.1 Hospitals
8.2 Specialty clinics
8.3 Home healthcare
8.4 Others


9. Countries

9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Europe

9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherlands
9.2.8 Turkey

9.3 Asia Pacific

9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Thailand
9.3.6 Malaysia
9.3.7 Indonesia
9.3.8 Australia
9.3.9 New Zealand

9.4 Latin America

9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina

9.5 Middle East & Africa

9.5.1 Saudi Arabia
9.5.2 United Arab Emirates
9.5.3 South Africa


10. Porter’s Five Forces Analysis

10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. SWOT Analysis

11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threats


12. Key Players Analysis

12.1 Silence Therapeutics plc

12.1.1 Overviews
12.1.2 Recent Developments
12.1.3 Product Portfolio
12.1.4 Revenue

12.2 Gilead Sciences Inc.

12.2.1 Overviews
12.2.2 Recent Developments
12.2.3 Product Portfolio
12.2.4 Revenue

12.3 Terumo Corporation

12.3.1 Overviews
12.3.2 Recent Developments
12.3.3 Product Portfolio
12.3.4 Revenue

12.4 Getinge AB

12.4.1 Overviews
12.4.2 Recent Developments
12.4.3 Product Portfolio
12.4.4 Revenue

12.5 Livanova Plc.

12.5.1 Overviews
12.5.2 Recent Developments
12.5.3 Product Portfolio
12.5.4 Revenue

12.6 Medtronic, Inc.

12.6.1 Overviews
12.6.2 Recent Developments
12.6.3 Product Portfolio
12.6.4 Revenue

12.7 Fresenius SE & Co.KGAA

12.7.1 Overviews
12.7.2 Recent Developments
12.7.3 Product Portfolio
12.7.4 Revenue

12.8 Nipro

12.8.1 Overviews
12.8.2 Recent Developments
12.8.3 Product Portfolio
12.8.4 Revenue

12.9 Pfizer Inc.

12.9.1 Overviews
12.9.2 Recent Developments
12.9.3 Product Portfolio
12.9.4 Revenue